A holistic approach to targeting disease with polymeric nanoparticles
Open accessThe DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted nanoparticles are engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy. Paradoxically, as this field has matured, the notion of targeting has been minimized to the concept of increasing the affinity of a nanoparticle for its target. This Opinion article outlines a holistic view of nanoparticle targeting, in which the route of administration, molecular characteristics and temporal control of the nanoparticles are potential design variables that must be considered simultaneously. This comprehensive vision for nanoparticle targeting will facilitate the integration of nanomedicines into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Encapsulation of hepcidin into biocompatible nanocarriers suitable for controlled release of therapeutics (Cheng et al., 2015) could theoretically address this issue.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Cheng et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Research works printed but not linked: 5
- Bertrand N Leroux JC The journey of a drug-carrier in the body: an anatomo-physiological perspective Journal of Controlled Release: Official Journal of the Controlled Release Society 161 152 163 2012 22001607
- Davis ME Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 1067 U140 2010 20305636 PMC2855406
- Wang YC Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 4546 4553 2008 18774604
- Kaur IP Kakkar S Nanotherapy for posterior eye diseases Journal of Controlled Release: Official Journal of the Controlled Release Society 2014 24862316
- Li H A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres Experimental Eye Research 83 824 833 2006 16822505
Cited by
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030118 · Cited by 942
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
Yong, T., Zhang, X., Bie, N., Zhang, H., Zhang, X., Li, F., Hakeem, A., Hu, J., Gan, L., Santos, H. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11718-4 · Cited by 806
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Polymeric nanoparticles: Promising platform for drug delivery
El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608
Poly(lactic acid) blends in biomedical applications
Saini, P., Arora, M., & Kumar, M. N. V. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.014 · Cited by 549
Synthesis and Biological Application of Polylactic Acid
Li, G., Zhao, M., Xu, F., Yang, B., Li, X., Meng, X., Teng, L., Sun, F., & Li, Y. (2020) · Molecules · doi:10.3390/molecules25215023 · Cited by 492
“Therefore, targeted drug systems are worthy of study [96].”
BackgroundHuang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Ai, X., Ho, C. J. H., Aw, J., Attia, A. B. E., Mu, J., Wang, Y., Wang, X., Wang, Y., Liu, X., Chen, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10432 · Cited by 433
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Feng, L., Dong, Z., Tao, D., Zhang, Y., & Liu, Z. (2018) · National Science Review · doi:10.1093/nsr/nwx062 · Cited by 426
Use of Nanoparticles in Tissue Engineering and Regenerative Medicine
Fathi-Achachelouei, M., Knopf-Marques, H., Ribeiro da Silva, C. E., Barthès, J., Bat, E., Tezcaner, A., & Vrana, N. E. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00113 · Cited by 390
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Lignin Nanoparticle as a Novel Green Carrier for the Efficient Delivery of Resveratrol
Dai, L., Liu, R., Hu, L.-Q., Zou, Z.-F., & Si, C.-L. (2017) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.7b01903 · Cited by 372
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
Dahlman, J. E., Kauffman, K. J., Xing, Y., Shaw, T. E., Mir, F. F., Dlott, C. C., Langer, R., Anderson, D. G., & Wang, E. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620874114 · Cited by 335
Brain-targeted drug delivery by manipulating protein corona functions
Zhang, Z., Guan, J., Jiang, Z., Yang, Y., Liu, J., Hua, W., Mao, Y., Li, C., Lu, W., Qian, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11593-z · Cited by 334
Cartilage-targeting drug delivery: can electrostatic interactions help?
Bajpayee, A. G., & Grodzinsky, A. J. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.210 · Cited by 325
Evolution of macromolecular complexity in drug delivery systems
Kakkar, A., Traverso, G., Farokhzad, O. C., Weissleder, R., & Langer, R. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0063 · Cited by 320
Effects of engineered nanoparticles on the innate immune system
Liu, Y., Hardie, J., Zhang, X., & Rotello, V. M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.011 · Cited by 315
Biodegradable polymers and constructs: A novel approach in drug delivery
Prajapati, S. K., Jain, A., Jain, A., & Jain, S. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.08.018 · Cited by 308
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Tonigold, M., Simon, J., Estupiñán, D., Kokkinopoulou, M., Reinholz, J., Kintzel, U., Kaltbeitzel, A., Renz, P., Domogalla, M. P., Steinbrink, K., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0171-6 · Cited by 289
Bioinspired exosome-like therapeutics and delivery nanoplatforms
Lu, M., & Huang, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119925 · Cited by 282
Paunovska, K., Sago, C. D., Monaco, C. M., Hudson, W. H., Castro, M. G., Rudoltz, T. G., Kalathoor, S., Vanover, D. A., Santangelo, P. J., Ahmed, R., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00432 · Cited by 277
Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery
Parodi, A., Molinaro, R., Sushnitha, M., Evangelopoulos, M., Martinez, J. O., Arrighetti, N., Corbo, C., & Tasciotti, E. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.020 · Cited by 266
Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting
Liu, J. F., Jang, B., Issadore, D., & Tsourkas, A. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1571 · Cited by 265
Parayath, N. N., Parikh, A., & Amiji, M. M. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00689 · Cited by 262
Siafaka, P., Üstündağ Okur, N., Karavas, E., & Bikiaris, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091440 · Cited by 219
Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries
Amani, H., Habibey, R., Hajmiresmail, S. J., Latifi, S., Pazoki-Toroudi, H., & Akhavan, O. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01689a · Cited by 219
Gao, J., Wang, S., & Wang, Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.003 · Cited by 218
Shekhar, N., & Mondal, A. (2024) · Polymer Bulletin · doi:10.1007/s00289-024-05252-7 · Cited by 174
Zhang, R., Fan, Q., Yang, M., Cheng, K., Lu, X., Zhang, L., Huang, W., & Cheng, Z. (2015) · Advanced Materials · doi:10.1002/adma.201502201 · Cited by 205
Paunovska, K., Da Silva Sanchez, A. J., Sago, C. D., Gan, Z., Lokugamage, M. P., Islam, F. Z., Kalathoor, S., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201807748 · Cited by 205
Outer membrane vesicles for vaccination and targeted drug delivery
Wang, S., Gao, J., & Wang, Z. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1523 · Cited by 192
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
Ediriwickrema, A., & Saltzman, W. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab500084g · Cited by 183
Self-citationNanoparticle-Based Antimicrobials: Surface Functionality is Critical
Gupta, A., Landis, R. F., & Rotello, V. M. (2016) · F1000Research · doi:10.12688/f1000research.7595.1 · Cited by 186
Prospective therapeutic potential of Tanshinone IIA: An updated overview
Ansari, M. A., Khan, F. B., Safdari, H. A., Almatroudi, A., Alzohairy, M. A., Safdari, M., Amirizadeh, M., Rehman, S., Equbal, M. J., & Hoque, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105364 · Cited by 179
Xiao, B., Xu, Z., Viennois, E., Zhang, Y., Zhang, Z., Zhang, M., Han, M. K., Kang, Y., & Merlin, D. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.020 · Cited by 183
Cell membrane-formed nanovesicles for disease-targeted delivery
Gao, J., Chu, D., & Wang, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.024 · Cited by 179
Polymeric nanoparticle vaccines to combat emerging and pandemic threats
Wibowo, D., Jorritsma, S. H. T., Gonzaga, Z. J., Evert, B., Chen, S., & Rehm, B. H. A. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120597 · Cited by 174
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
Zhao, Y., Wang, W., Guo, S., Wang, Y., Miao, L., Xiong, Y., & Huang, L. (2016) · Nature Communications · doi:10.1038/ncomms11822 · Cited by 171
Recent advances in nanotechnology-based drug delivery systems for the kidney
Oroojalian, F., Charbgoo, F., Hashemi, M., Amani, A., Yazdian-Robati, R., Mokhtarzadeh, A., Ramezani, M., & Hamblin, M. R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.027 · Cited by 168
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier
Dal Magro, R., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.039 · Cited by 165
Shim, M. K., Park, J., Yoon, H. Y., Lee, S., Um, W., Kim, J.-H., Kang, S.-W., Seo, J.-W., Hyun, S.-W., Park, J. H., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.11.032 · Cited by 169
Ahmad, A., Imran, M., & Sharma, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112463 · Cited by 198
Abd Ellah, N. H., & Abouelmagd, S. A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1213238 · Cited by 164
Paunovska, K., Gil, C. J., Lokugamage, M. P., Sago, C. D., Sato, M., Lando, G. N., Gamboa Castro, M., Bryksin, A. V., & Dahlman, J. E. (2018) · ACS Nano · doi:10.1021/acsnano.8b03640 · Cited by 160
Cellular distribution of injected PLGA-nanoparticles in the liver
Park, J.-K., Utsumi, T., Seo, Y.-E., Deng, Y., Satoh, A., Saltzman, W. M., & Iwakiri, Y. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.01.013 · Cited by 153
Self-citationNanostructured particles assembled from natural building blocks for advanced therapies
Ju, Y., Liao, H., Richardson, J. J., Guo, J., & Caruso, F. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00343g · Cited by 159
Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys
Tietjen, G. T., Hosgood, S. A., DiRito, J. R., Cui, J., Deep, D., Song, E., Kraehling, J. R., Piotrowski-Daspit, A. S., Kirkiles-Smith, N. C., Al‐Lamki, R. S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam6764 · Cited by 160
Self-citationApplication Of Nanotechnology In Agriculture And Food Industry, Its Prospects And Risks
Jampílek, J., & Kráľová, K. (2015) · Ecological Chemistry and Engineering S · doi:10.1515/eces-2015-0018 · Cited by 179
Nikitin, M. P., Zelepukin, I. V., Shipunova, V. O., Sokolov, I. L., Deyev, S. M., & Nikitin, P. I. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0581-2 · Cited by 158
Wu, L.-P., Ahmadvand, D., Su, J., Hall, A., Tan, X., Farhangrazi, Z. S., & Moghimi, S. M. (2019) · Nature Communications · doi:10.1038/s41467-019-12554-2 · Cited by 140
Ahmad, A., BANAT, F. A., AlSafar, H. S., & Hasan, S. W. (2022) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-02581-3 · Cited by 152
Khalaf, E. M., Abood, N. A., Atta, R. Z., Ramírez‐Coronel, A. A., Alazragi, R. S., Romero‐Parra, R. M., Abed, O. H., Abosaooda, M., Jalil, A. T., Mustafa, Y. F., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123354 · Cited by 142
Focus on Fundamentals: Achieving Effective Nanoparticle Targeting
Tietjen, G. T., Bracaglia, L. G., Saltzman, W. M., & Pober, J. S. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.05.003 · Cited by 147
Self-citationBiodegradable Inorganic Nanovector: Passive versus Active Tumor Targeting in siRNA Transportation
Park, D., Cho, J., Kwon, O., Yun, C., & Choy, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510844 · Cited by 140
Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy
Guimarães, P. P. G., Gaglione, S. A., Sewastianik, T., Carrasco, R. D., Langer, R., & Mitchell, M. J. (2018) · ACS Nano · doi:10.1021/acsnano.7b05876 · Cited by 140
Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review
Ranasinghe, P., Addison, M. L., Dear, J. W., & Webb, D. J. (2023) · British Journal of Pharmacology · doi:10.1111/bph.15972 · Cited by 138
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
Zhao, Y., Fay, F., Hak, S., Manuel Perez-Aguilar, J., Sanchez-Gaytan, B. L., Goode, B., Duivenvoorden, R., de Lange Davies, C., Bjørkøy, A., Weinstein, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms11221 · Cited by 134
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
Dong, X., Chu, D., & Wang, Z. (2017) · Theranostics · doi:10.7150/thno.18069 · Cited by 136
Jan, N., Madni, A., Khan, S., Shah, H., Akram, F., Khan, A., Ertas, D., Bostanudin, M. F., Contag, C. H., Ashammakhi, N. A., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10441 · Cited by 150
Selective Nanoparticle Targeting of the Renal Tubules
Williams, R. M., Shah, J., Tian, H. S., Chen, X., Geissmann, F., Jaimes, E. A., & Heller, D. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09843 · Cited by 137
Particle Targeting in Complex Biological Media
Dai, Q., Bertleff‐Zieschang, N., Braunger, J. A., Björnmalm, M., Cortez‐Jugo, C., & Caruso, F. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700575 · Cited by 139
Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution
Sago, C. D., Lokugamage, M. P., Islam, F. Z., Krupczak, B. R., Sato, M., & Dahlman, J. E. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08976 · Cited by 126
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases
Lim, Y. H., Tiemann, K. M., Hunstad, D. A., Elsabahy, M., & Wooley, K. L. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1401 · Cited by 131
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
Zuo, Z.-Q., Chen, K., Yu, X., Zhao, G., Shen, S., Cao, Z., Luo, Y., Wang, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.014 · Cited by 131
Clinical applications of nanomedicine in cancer therapy
Norouzi, M., Amerian, M., Amerian, M., & Atyabi, F. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.017 · Cited by 130
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles
García-Díaz, M., Birch, D., Wan, F., & Nielsen, H. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.11.002 · Cited by 129
Improving nanoparticle diffusion through tumor collagen matrix by photo-thermal gold nanorods
Raeesi, V., & Chan, W. C. W. (2016) · Nanoscale · doi:10.1039/c5nr08463f · Cited by 122
Nano- and neurotoxicology: An emerging discipline
Bencsik, A. A., Lestaevel, P., & Canu, I. G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.003 · Cited by 127
Engineering polyphenol-based polymeric nanoparticles for drug delivery and bioimaging
Wang, X., Fan, Y., Yan, J., & Yang, M. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135661 · Cited by 123
Microfluidic generation of egg-derived protein microcarriers for 3D cell culture and drug delivery
Liu, Y., Huang, Q., Wang, J., Fu, F., Ren, J., & Zhao, Y. (2017) · 中国科学通报:英文版 · doi:10.1016/j.scib.2017.09.006 · Cited by 115
Zhang, Y., Liu, G., Sun, M., & Lü, X. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0372 · Cited by 119
Fang, Y., Jiang, Y., Zou, Y., Meng, F., Zhang, J., Deng, C., Sun, H., & Zhong, Z. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.007 · Cited by 116
Steinbach-Rankins, J. M., Seo, Y.-E., & Saltzman, W. M. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.029 · Cited by 117
Self-citationMechanistic Understanding of the Biological Responses to Polymeric Nanoparticles
Kenry, K., Yeo, T., Manghnani, P. N., Middha, E., Pan, Y., Chen, H., Lim, C. T., & Liu, B. (2020) · ACS Nano · doi:10.1021/acsnano.9b10195 · Cited by 115
In vivo chemical reprogramming of astrocytes into neurons
Ma, Y., Xie, H., Du, X., Wang, L., Jin, X., Zhang, Q., Han, Y., Sun, S., Wang, L., Li, X., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00243-8 · Cited by 99
Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections
Abramson, A., Kirtane, A. R., Shi, Y., Zhong, G., Collins, J. E., Tamang, S. M., Ishida, K., Hayward, A. M., Wainer, J., Rajesh, N. U., et al. (2022) · Matter · doi:10.1016/j.matt.2021.12.022 · Cited by 111
Recent Advances in Biodegradable Polymers and Their Biological Applications: A Brief Review
Alaswad, S. O., Mahmoud, A. S., & Arunachalam, P. (2022) · Polymers · doi:10.3390/polym14224924 · Cited by 114
Lazaridou, M., Christodoulou, E., Nerantzaki, M., Kostoglou, M., Lambropoulou, D., Katsarou, A., Pantopoulos, K., & Bikiaris, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030238 · Cited by 106
Fraguas‐Sánchez, A. I., Torres‐Suárez, A. I., Cohen, M., Delié, F., Bastida-Ruiz, D., Yart, L., Martín‐Sabroso, C., & Fernández-Carballido, A. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050439 · Cited by 113
Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
Xu, C., Zhang, H., Sun, C., Liu, Y., Shen, S., Yang, X., Zhu, Y., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.031 · Cited by 108
Zhu, W., Lee, S., Castro, N. J., Yan, D., Keidar, M., & Zhang, L. G. (2016) · Scientific Reports · doi:10.1038/srep21974 · Cited by 106
Cui, J., Qin, L., Zhang, J., Abrahimi, P., Li, H., Li, G., Tietjen, G. T., Tellides, G., Pober, J. S., & Mark Saltzman, W. (2017) · Nature Communications · doi:10.1038/s41467-017-00297-x · Cited by 101
Self-citationIn Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Cevaal, P. M., Ali, A., Czuba‐Wojnilowicz, E., Symons, J., Lewin, S. R., Cortez‐Jugo, C., & Caruso, F. (2021) · ACS Nano · doi:10.1021/acsnano.0c09514 · Cited by 106
Mazzarino, L., Loch-Neckel, G., Bubniak, L. D. S., Ourique, F., Otsuka, I., Halila, S., Pedrosa, R. C., Santos‐Silva, M. C., Lemos‐Senna, E., Muniz, E. C., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv114 · Cited by 104
Glycogen as a Building Block for Advanced Biological Materials
Besford, Q. A., Cavalieri, F., & Caruso, F. (2019) · Advanced Materials · doi:10.1002/adma.201904625 · Cited by 106
Surface chemistry governs cellular tropism of nanoparticles in the brain
Song, E., Gaudin, A., King, A. R., Seo, Y.-E., Suh, H., Deng, Y., Cui, J., Tietjen, G. T., Huttner, A. J., & Saltzman, W. M. (2017) · Nature Communications · doi:10.1038/ncomms15322 · Cited by 103
Self-citationSaucier-Sawyer, J. K., Deng, Y., Seo, Y.-E., Cheng, C. J., Zhang, J., Quijano, E., & Saltzman, W. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1065833 · Cited by 98
Self-citationCurrent Advances of Nanocarrier Technology-Based Active Cosmetic Ingredients for Beauty Applications
Zhou, H., Luo, D., Chen, D., Tan, X., Bai, X., Liu, Z., Yang, X., & Liu, W. (2021) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s313429 · Cited by 95
Cell membrane-derived Nanoparticles: Emerging Clinical Opportunities for Targeted Drug Delivery
Yurkin, S. T., & Wang, Z. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0100 · Cited by 102
Nanomedicine Delivery: does Protein Corona Route to the Target or off Road?
Maiolo, D., Del Pino, P., Metrangolo, P., Parak, W. J., & Baldelli Bombelli, F. (2015) · Nanomedicine · doi:10.2217/nnm.15.163 · Cited by 98
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
Tawfik, M., Chen, F., Goldberg, J. L., & Sabel, B. A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02287-3 · Cited by 101
Zou, Y., Fang, Y., Meng, H., Meng, F., Deng, C., Zhang, J., & Zhong, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.060 · Cited by 98
Metadata
- Authors
- Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M.
- Affiliations
- Yale University (US)
- Corresponding author
- Saltzman, W. Mark
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-01-19
- Volume
- 14
- Issue
- 4
- Pages
- 239-247
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC4451203
- OpenAlex
- W2041271505
- Cited by
- 480
- References
- 135
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 31 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 42 · 2019: 40 · 2018: 46 · 2017: 63 · 2016: 60 · 2015: 27
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-04-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Cancer Institute (R01CA149128, F32CA174247, CA149128)
- National Institute of Allergy and Infectious Diseases (R01AI112443, T32AI089704, AI106992, R56AI106922, AI112443)
- National Institute of Biomedical Imaging and Bioengineering (EB00487, R01EB000487)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- targeted drug delivery, polymeric nanoparticles, nanomedicine, nanoparticle targeting, route of administration, nanoparticle design, clinical translation
- MeSH terms
- Animals, Humans, Polymers, Drug Delivery Systems, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.